A study to evaluate the efficacy and safety of rosuvastatin in the long-term treatment of hypercholesterolaemic subjects with coronary heart disease as measured by intravascular ultrasonography.

Next Previous
Trial Profile

A study to evaluate the efficacy and safety of rosuvastatin in the long-term treatment of hypercholesterolaemic subjects with coronary heart disease as measured by intravascular ultrasonography.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Aug 2016

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Coronary disorders; Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms COSMOS
  • Sponsors AstraZeneca

    • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 30 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Dec 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top